Tumor-associated trypsin inhibitor as a prognostic factor during follow-up of bladder cancer
Author:
Publisher
Elsevier BV
Subject
Urology
Reference20 articles.
1. Bladder cancer;Foresman;Semin Surg Oncol,1997
2. Urothelial dysplasia concomitant with bladder tumours as a determinant factor for future new occurrences;Wolf;Lancet,1983
3. Prognostic markers in bladder cancer;Stein;J Urol,1998
4. Cyclin D1 expression in transitional cell carcinoma of the bladder;Tut;Br J Cancer,2001
5. Current bladder tumor tests;Lokeshwar;J Urol,2001
Cited by 35 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Identification and Exploration of Serine Peptidase Inhibitor Kazal Type I (SPINK1) as a Potential Biomarker Correlated with the Progression of Non-Small Cell Lung Cancer;Cell Biochemistry and Biophysics;2022-10-04
2. Serine protease inhibitor Kazal type 1 (SPINK1) promotes proliferation, migration, invasion and radiation resistance in rectal cancer patients receiving concurrent chemoradiotherapy: a potential target for precision medicine;Human Cell;2022-09-02
3. Tumor-Associated Trypsin Inhibitor (TATI) as a Biomarker of Poor Prognosis in Oropharyngeal Squamous Cell Carcinoma Irrespective of HPV Status;Cancers;2021-06-04
4. Diagnostic and Prognostic Potential of Biomarkers CYFRA 21.1, ERCC1, p53, FGFR3 and TATI in Bladder Cancers;International Journal of Molecular Sciences;2020-05-09
5. Prognostic value of the combined expression of tumor-associated trypsin inhibitor (TATI) and p53 in patients with bladder cancer undergoing radical cystectomy;Cancer Biomarkers;2019-11-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3